Les Turner Symposium on ALS Celebrates Advancements - News Center
Briefly

Les Turner Symposium on ALS Celebrates Advancements - News Center
"Our goal is to start new collaborations and foster new ideas such that what we find and what we discover will be translated into effective treatment strategies. It is our obligation to connect the dots so that patients can actually live a better day,"
"This symposium is a powerful example of the progress made possible through our longstanding partnership with Northwestern Medicine,"
Northwestern scientists, clinicians and people living with ALS convened at Northwestern Memorial Hospital on November 3 for the 15th annual Les Turner Symposium on ALS in a hybrid format. Presentations and a poster session highlighted new research into amyotrophic lateral sclerosis, a progressive neurodegenerative disease that affects motor neurons and causes muscle weakness and atrophy. An estimated 350,000 people worldwide currently live with ALS, which has an average survival of about three years. Organizers emphasized starting new collaborations, translating discoveries into effective treatment strategies, and improving patient care. The Les Turner ALS Foundation and Center support research and life-enhancing treatment and have partnered with Northwestern Medicine since 1979.
Read at News Center
Unable to calculate read time
[
|
]